Figure 1.
The impact of CMV reactivation on NRM and strarification of CMV reactivation risk after transplantation. (A) The impact of CMV reactivation on NRM after allo-HSCT by a landmark analysis at day 100. (B) Cumulative incidence of CMV reactivation stratified into 3 groups by the number of significant risk factors.

The impact of CMV reactivation on NRM and strarification of CMV reactivation risk after transplantation. (A) The impact of CMV reactivation on NRM after allo-HSCT by a landmark analysis at day 100. (B) Cumulative incidence of CMV reactivation stratified into 3 groups by the number of significant risk factors.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal